Skip to main
ARWR
ARWR logo

Arrowhead Pharmaceuticals (ARWR) Earnings Dates & Reports

Arrowhead Pharmaceuticals (ARWR) Most Recent Earnings

Report DateAug 7, 2025
Period EndingQ3 2025
Est. EPS-$1.04
Actual EPS-$1.26
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Arrowhead Pharmaceuticals (ARWR) Earnings per Share (EPS) History

Signup for full access
Browse free

Arrowhead Pharmaceuticals (ARWR) Latest Earnings

The value each ARWR share was expected to gain vs. the value each share gained.

Arrowhead Pharmaceuticals (ARWR) reported its most recent earnings on Aug 7, 2025 for Q3 2025, posting earnings per share (EPS) of -$1.26. This exceeded analysts' expectations of -$1.04 by 21.15%, marking a Miss.

For comparison, Arrowhead Pharmaceuticals reported EPS of -$1.38 in the same quarter last year.

The company is expected to announce its next earnings report on 11/25/2025, with analysts projecting an EPS of -$0.18.

Arrowhead Pharmaceuticals (ARWR) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Nov 25, 2025
-$0.18Next earnings call Nov. 25, 2025
Q3 2025Aug 7, 2025
-$1.04-$1.26+21.15%
Q2 2025May 12, 2025
-$0.46$2.75-697.83%
Q1 2025Feb 10, 2025
-$0.72-$1.39+93.06%
Q4 2024Nov 26, 2024
-$0.92-$1.37+48.91%
View all

Arrowhead Pharmaceuticals (ARWR) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Arrowhead Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 7, 2025
May 12, 2025
Feb 10, 2025
Nov 26, 2024

Arrowhead Pharmaceuticals (ARWR) Earnings FAQs

Arrowhead Pharmaceuticals (ARWR) last reported earnings on Aug 7, 2025 for Q3 2025, posting an EPS of -$1.26, which Miss the estimate of -$1.04 by 21.15%.

For Q3 2025, Arrowhead Pharmaceuticals (ARWR) reported an EPS of -$1.26, missing analysts' estimate of -$1.04 by 21.15%.

For Q3 2025, Arrowhead Pharmaceuticals (ARWR) Miss expectations with an actual EPS of -$1.26 vs. an estimated EPS of -$1.04.

Following the last earnings report on Aug 7, 2025, Arrowhead Pharmaceuticals (ARWR)'s stock price moved — from — to —.

The next Arrowhead Pharmaceuticals (ARWR) earnings call is scheduled for Nov. 25, 2025, where executives will discuss financial results and outlook.

Arrowhead Pharmaceuticals (ARWR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.